KiệtP.H.T., PhươngL.T.M., TrungN. Đức and MaiK.T.T. 2025. Cost-effectiveness analysis of ceritinib as first-line treatment for patients with locally advanced or metastatic ALK-positive non-small cell lung cancer in Vietnam. Tạp chí Y Dược lâm sàng 108. 20, 7 (Dec. 2025). DOI:https://doi.org/10.52389/ydls.v20i7.2849.